Huateng Pharma to Exhibit at CPHI China 2024
Shanghai, China — Hunan Huateng Pharmaceutical Co., Ltd. is pleased to announce its participation in CPHI China 2024, a premier event in the global pharmaceutical industry. The company invites attendees to visit its booth to explore a range of innovative products and solutions designed to advance the bio-pharmaceutical sector.
Event Details:
- Date: 19-21 June, 2024
- Location: Shanghai New International Expo Center
- Booth Number: W3P16
Huateng Pharma is recognized globally as a leading supplier of Polyethylene Glycol (PEG) derivatives and a Contract Development and Manufacturing Organization (CDMO) specializing in Active Pharmaceutical Ingredients (APIs) and intermediates. The company offers comprehensive support from R&D lab supply to commercial production, leveraging advanced PEG technology.
Key Offerings:
- Extensive Range of PEG Derivatives: A wide selection of PEG derivatives tailored to meet diverse pharmaceutical needs.
- Advanced CDMO Services: End-to-end CDMO services for APIs and intermediates, ensuring smooth transitions from development to commercial production.
- Customized Raw Material Solutions: Utilizing state-of-the-art technology, Huateng Pharma offers bespoke raw material solutions for the chemical pharmaceutical industry.
Dr. Deng, CEO of Huateng Pharma, expressed his enthusiasm for the upcoming event: "Huateng Pharma is excited to participate in CPHI China 2024. We extend a warm welcome to our customers and industry partners to visit our booth. This event is a significant opportunity for us to showcase our latest innovations and demonstrate our ongoing commitment to advancing the bio-pharmaceutical industry. We look forward to engaging with attendees, understanding their needs, and exploring new opportunities for collaboration."
Why Visit Booth W3P16:
- Innovative Products: Discover the latest advancements in PEG derivatives and CDMO services.
- Expert Consultation: Interact with a team of experts to discuss potential collaborations and customized solutions.
- Networking Opportunities: Connect with industry professionals and gain insights into the latest industry trends and developments.
Huateng Pharma is dedicated to providing high-quality, innovative solutions that support success in the bio-pharmaceutical sector. The company eagerly anticipates connecting with industry professionals at CPHI China 2024 to share its cutting-edge advancements and discuss how it can meet pharmaceutical needs.
For more information, please visit the https://us.huatengsci.com/ or contact sales@huatengusa.com .
About Hunan Huateng Pharmaceutical Co., Ltd.
Hunan Huateng Pharmaceutical Co., Ltd. is a global leader in supplying PEG derivatives and CDMO services for APIs and intermediates. The company's mission is to deliver innovative, high-quality solutions to the pharmaceutical industry, supporting clients from research and development through to commercial production.